First City Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

First City Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,305	Closed	-$253K	–	181
2020 Q3	$253K	Buy	5,305 +1,475	+39%	+$81.9K	0.09%	167
2020 Q2	$226K	Buy	+3,830	New	+$213K	0.17%	130
2020 Q1	–	Sell	-3,830	Closed	-$231K	–	125
2019 Q4	$231K	Hold	3,830	–	–	0.16%	129
2019 Q3	$229K	Hold	3,830	–	–	0.17%	126
2019 Q2	$246K	Hold	3,830	–	–	0.18%	119
2019 Q1	$311K	Sell	3,830 -1,500	-28%	-$96.8K	0.22%	115
2018 Q4	$288K	Hold	5,330	–	–	0.22%	112
2018 Q3	$275K	Hold	5,330	–	–	0.18%	121
2018 Q2	$222K	Hold	5,330	–	–	0.16%	128
2018 Q1	$235K	Hold	5,330	–	–	0.18%	124
2017 Q4	$268K	Hold	5,330	–	–	0.18%	121
2017 Q3	$270K	Hold	5,330	–	–	0.19%	120
2017 Q2	$271K	Hold	5,330	–	–	0.2%	115
2017 Q1	$214K	Hold	5,330	–	–	0.16%	120
2016 Q4	$255K	Buy	+5,330	New	+$211K	0.19%	119
2016 Q2	–	Sell	-5,130	Closed	-$208K	–	315
2016 Q1	$208K	Sell	5,130 -1,535	-23%	-$62.3K	0.14%	124
2015 Q4	$413K	Hold	6,665	–	–	0.28%	88
2015 Q3	$269K	Buy	6,665 +1,035	+18%	+$53.6K	0.2%	111
2015 Q2	$324K	Buy	5,630 +855	+18%	+$54.4K	0.23%	101
2015 Q1	$304K	Sell	4,775 -25	-0.5%	-$1.7K	0.21%	106
2014 Q4	$296K	Hold	4,800	–	–	0.2%	109
2014 Q3	$186K	Hold	4,800	–	–	0.13%	143
2014 Q2	$165K	Hold	4,800	–	–	0.12%	153
2014 Q1	$207K	Buy	+4,800	New	+$233K	0.15%	140
2013 Q4	–	Sell	-5,500	Closed	-$206K	–	156
2013 Q3	$206K	Buy	+5,500	New	+$164K	0.17%	150

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

First City Capital Management's IONS Position: Q4 2020 in Review

First City Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2020, closing a stake of 5,305 shares — an estimated $253K sold.

First City Capital Management first reported a position in IONS in Q3 2013 and held it in 25 quarters. The position peaked at $413K in Q4 2015. 382 funds tracked by Wall St. Rank hold IONS as of Q4 2020.

First City Capital Management reported no remaining Ionis Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
First City Capital Management sold 5,305 Ionis Pharmaceuticals shares in Q4 2020, an estimated $253K.
First City Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 25 quarters.
First City Capital Management's Ionis Pharmaceuticals position peaked at $413K in Q4 2015.
382 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2020.

Based on First City Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.